Published ahead of print on September 22, 2005, doi:10.1164/rccm.200505-704OC
Am. J. Respir. Crit. Care Med., Volume 173, Number 1, January 2006, 71-78
A more recent version of this article appeared on January 1, 2006
Submitted on May 5, 2005
Accepted on September 21, 2005
Systemic, Upper and Lower Airway Inflammation at Exacerbation of COPD
John R Hurst1, Wayomi R Perera1, Tom M.A. Wilkinson1, Gavin C Donaldson1, and Jadwiga A Wedzicha1*
1 St. Bartholomew's Hospital, Academic Unit of Respiratory Medicine, London, United Kingdom
* To whom correspondence should be addressed. E-mail: j.a.wedzicha{at}medsch.ucl.ac.uk.
Rationale: In addition to pulmonary involvement, stable COPD is associated with nasal and systemic inflammation. While exacerbations of COPD are associated with increased
pulmonary and systemic inflammation, determinants of the systemic response remain obscure, and nor is it known whether there is nasal involvement. Objectives: To investigate upper airway, lower airway, and systemic inflammation at exacerbation of COPD. Methods: We sampled sputum, nasal wash and serum from 41 exacerbations (East London cohort) for analysis of pathogenic microorganisms and inflammatory indices (sputum/ nasal wash leukocytes, interleukin (IL)6, IL8 and myeloperoxidase (MPO); serum IL6 and C-Reactive Protein (CRP)). Values were compared with stable COPD. Measurements and Main Results: Exacerbation of COPD is associated with greater nasal, sputum and serum inflammation than the stable state. At exacerbation, inflammatory markers were highly correlated within nasal wash and serum (all r 0.62 p<0.001) but not sputum. The degree of upper airway inflammation correlated with the degree of lower airway inflammation (eg nasal wash/ sputum MPO, r=0.50, p=0.001). The degree of systemic inflammation correlated with the degree of lower airway inflammation (eg serum IL6/ sputum IL8, r=0.35, p=0.026), and was greater in the presence of a sputum bacterial pathogen (29.0g/dl CRP difference, p=0.002). We did not find relationships between the upper airway and systemic compartments. Conclusions: Exacerbation of COPD is associated with pan-airway inflammation; the systemic inflammatory response is proportional to that occurring in the lower airway and greater in the presence of a bacterial pathogen.
Key words: Nose, Pathogen, Cytokine
This article has been cited by other articles:

|
 |

|
 |
 
T. Seemungal, A. Sykes, and and the ICEAD Contributors
Recent advances in exacerbations of COPD
Thorax,
October 1, 2008;
63(10):
850 - 852.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Falk, O. A. Minai, and Z. Mosenifar
Inhaled and Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
506 - 512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Murphy, A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi
Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
April 15, 2008;
177(8):
853 - 860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Churg, M. Cosio, and J. L. Wright
Mechanisms of cigarette smoke-induced COPD: insights from animal models
Am J Physiol Lung Cell Mol Physiol,
April 1, 2008;
294(4):
L612 - L631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi, C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T. F. Murphy
Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
March 1, 2008;
177(5):
491 - 497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J.,
February 1, 2008;
31(2):
416 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bozinovski, A. Hutchinson, M. Thompson, L. MacGregor, J. Black, E. Giannakis, A.-S. Karlsson, R. Silvestrini, D. Smallwood, R. Vlahos, et al.
Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
February 1, 2008;
177(3):
269 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Baik, J. Kim, R. D. Abbott, S. Joo, K. Jung, S. Lee, J. Shim, K. In, K. Kang, S. Yoo, et al.
Association of Snoring With Chronic Bronchitis
Arch Intern Med,
January 28, 2008;
168(2):
167 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Welte
Acute Exacerbation of Chronic Obstructive Pulmonary Disease: More a Functional than an Inflammatory Problem?
Am. J. Respir. Crit. Care Med.,
January 15, 2008;
177(2):
130 - 131.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Wedzicha and J. R. Hurst
Structural and Functional Co-conspirators in Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS,
December 1, 2007;
4(8):
602 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy
Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations
Proceedings of the ATS,
December 1, 2007;
4(8):
626 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J Hancox, R. Poulton, J. M Greene, S. Filsell, C. R McLachlan, F. Rasmussen, D R. Taylor, M. J A Williams, A. Williamson, and M. R Sears
Systemic inflammation and lung function in young adults
Thorax,
December 1, 2007;
62(12):
1064 - 1068.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Agusti
Systemic Effects of Chronic Obstructive Pulmonary Disease: What We Know and What We Don't Know (but Should)
Proceedings of the ATS,
October 1, 2007;
4(7):
522 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Anzueto, S. Sethi, and F. J. Martinez
Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
October 1, 2007;
4(7):
554 - 564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Powrie, T. M. A. Wilkinson, G. C. Donaldson, P. Jones, K. Scrine, K. Viel, S. Kesten, and J. A. Wedzicha
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
Eur. Respir. J.,
September 1, 2007;
30(3):
472 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Singh
Inhaled steroids in exacerbations of COPD
Eur. Respir. J.,
August 1, 2007;
30(2):
398 - 398.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Edwards, J. Haas, R. A. Panettieri Jr., M. Johnson, and S. L. Johnston
Corticosteroids and beta2 Agonists Differentially Regulate Rhinovirus-induced Interleukin-6 via Distinct Cis-acting Elements
J. Biol. Chem.,
May 25, 2007;
282(21):
15366 - 15375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Perera, J. R. Hurst, T. M. A. Wilkinson, R. J. Sapsford, H. Mullerova, G. C. Donaldson, and J. A. Wedzicha
Inflammatory changes, recovery and recurrence at COPD exacerbation
Eur. Respir. J.,
March 1, 2007;
29(3):
527 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J R Hurst and J A Wedzicha
What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines
Thorax,
March 1, 2007;
62(3):
198 - 199.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J A Wedzicha and J R Hurst
Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism
Thorax,
February 1, 2007;
62(2):
103 - 104.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. A. Wilkinson, J. A. Bilello, G. W. Hagan, R. S. Vessey, and J. A. Wedzicha
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
October 15, 2006;
174(8):
867 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Takabatake, Y. Shibata, S. Abe, T. Wada, J.-i. Machiya, A. Igarashi, Y. Tokairin, G. Ji, H. Sato, M. Sata, et al.
A Single Nucleotide Polymorphism in the CCL1 Gene Predicts Acute Exacerbations in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
October 15, 2006;
174(8):
875 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Phua, E. S. C. Koay, D. Zhang, L. K. Tai, X. L. Boo, K. C. Lim, and T. K. Lim
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
Eur. Respir. J.,
October 1, 2006;
28(4):
695 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mallia and S. L. Johnston
How viral infections cause exacerbation of airway diseases.
Chest,
October 1, 2006;
130(4):
1203 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. E. Hargreave and K. Parameswaran
Asthma, COPD and bronchitis are just components of airway disease.
Eur. Respir. J.,
August 1, 2006;
28(2):
264 - 267.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Papi, F. Luppi, F. Franco, and L. M. Fabbri
Pathophysiology of Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2006;
3(3):
245 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|